2. Academic Validation
  3. Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy

Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy

  • Signal Transduct Target Ther. 2023 Dec 11;8(1):448. doi: 10.1038/s41392-023-01696-x.
Anna Brichkina 1,  Roman Suezov 2,  Magdalena Huber 3
Affiliations

Affiliations

  • 1 Institute of Systems Immunology, Member of the German Center for Lung Research (DZL), Philipps University of Marburg, 35043, Marburg, Germany. anna.brichkina@staff.uni-marburg.de.
  • 2 Institute of Systems Immunology, Member of the German Center for Lung Research (DZL), Philipps University of Marburg, 35043, Marburg, Germany.
  • 3 Institute of Systems Immunology, Member of the German Center for Lung Research (DZL), Philipps University of Marburg, 35043, Marburg, Germany. magdalena.huber@staff.uni-marburg.de.
PMID: 38072988 DOI: 10.1038/s41392-023-01696-x
Figures
Products